Natco Pharma’s board declared a second interim dividend of ₹1.50 per equity share, with a face value of ₹2, for FY 2024-25.

NIA contract valued at ₹136 crore includes demolition, design, construction, and furnishing for four buildings located in ...

The Telangana Stage-II project will further enhance India’s power generation capabilities, boosting infrastructure and ...

Operating EBITDA surged 31.7% to ₹435 Crore this quarter from ₹330.2 Crore in Q2 FY24, with EBITDA margin improving to 21.9%, ...

Bank of India recorded a net profit of Rs 2,374 crore for Q2FY25, a 63% increase over the same time the previous year, ...

Over the next five years, 500 compressed biogas plants (CBG) would be established in Andhra Pradesh thanks to an investment ...

The licence authorizes Raneal Advanced Systems to produce, assemble, and test microwave submodules used for command and ...

Discover the benefits of becoming a sub-broker franchise in India. Read about certifications, clients, premises, equipment ...

EBITDA decreased by 10.2% to ₹783.4 Crore in the second quarter of this fiscal year, from ₹872.4 Crore in Q2 of FY24.

Novelis' adjusted EBITDA of $462 million was down 5% due to lower metal benefits, an unfavourable product mix.

The company's revenue from operations declined 12.5% to ₹2,038.2 Crore, compared to ₹2,329.3 Crore the previous year.

The company's EBITDA margins also fell, to 13.9% from 15.6% a year ago, showing persistent challenges on operating efficiency ...